Back to Susquehanna International Group, LLP Susquehanna International Group, LLP

SMMT

23 quarters

Position history for Susquehanna International Group, LLPSusquehanna International Group, LLP's holdings in Summit Therapeutics Inc.

Yes. Susquehanna International Group holds 521,339 shares of SMMT (Summit Therapeutics), worth $7.6M, as of its Q2 2026 13F filing. It reduced the position by 82,594 shares (-13.7%) from Q1 2026. Susquehanna International Group has held SMMT since Q1 2026, across 2 quarterly 13F filings.

Current Value

$7.6M

Current Shares

521,339

Total Value Change

+$7.5M

Total Shares Change

+493,453

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
521,339
-13.7%
$7.6M0.0%$14.57
0
2026-Q1
New
603,933
-
$11.5M0.0%$15.11
39
2025-Q4
Exited
0
-100.0%
$00.0%$17.49
0
2025-Q3
Decreased
246,562
-17.8%
$5.1M0.0%$20.66
0
2025-Q2
Increased
299,973
+18.3%
$6.4M0.0%$21.28
32
2025-Q1
Increased
253,499
+228.3%
$4.9M0.0%$19.29
43
2024-Q4
Decreased
77,224
-78.9%
$1.4M0.0%$17.85
0
2024-Q3
Increased
366,395
+44.4%
$8M0.0%$20.89
37
2024-Q2
Increased
253,801
+57.3%
$2M0.0%$7.80
37
2024-Q1
Decreased
161,338
-30.0%
$667,9390.0%$4.14
0
2023-Q4
Increased
230,350
+82.3%
$601,2140.0%$2.61
38
2023-Q3
Decreased
126,371
-66.7%
$236,3140.0%$1.87
0
2023-Q2
Decreased
379,342
-77.5%
$952,1490.0%$2.51
0
2023-Q1
Increased
1.7M
+502.1%
$3M0.0%$1.63
43
2022-Q4
Increased
280,424
+243.2%
$1.2M0.0%$4.25
41
2022-Q3
Increased
81,707
+245.7%
$97,0000.0%$1.15
24
2022-Q2
New
23,637
-
$24,0000.0%$0.97
29
2022-Q1
Exited
0
-100.0%
$00.0%$2.45
0
2021-Q4
Increased
14,461
+12.8%
$39,0000.0%$2.69
15
2021-Q3
New
12,820
-
$64,0000.0%$4.83
32
2021-Q2
Exited
0
-100.0%
$00.0%$7.43
0
2021-Q1
Increased
133,808
+379.8%
$785,0000.0%$5.87
40
2020-Q4
New
27,886
-
$131,0000.0%$4.70
34

Other major holders of SMMT: Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used